app

Meeting Coverage

AAD Video Pearls

Video Pearls from the American Academy of Dermatology

Durability of Tralokinumab in Atopic Dermatitis Seen in Extension Trial

Open-label ECZTEND study looked at subset of patients on IL-13 blocker for up to 2 years

image

Latest AAD Video Pearls Meeting Coverage

Etrasimod Shows Promise for Atopic Dermatitis

New safety and efficacy data highlight potential, Emma Guttman-Yassky explains

May 24, 2021
'Exciting' Future for Topical Ruxolitinib in Atopic Dermatitis

Potential as first-line agent for mild to moderate cases, says Jonathan Silverberg

May 17, 2021
Flexible Abrocitinib Dosing Effective in Atopic Dermatitis

Responders saw reduced flaring at both 100 and 200 mg

May 10, 2021
New Kids on the Block for Treating Melasma

"We finally have something that's not hydroquinone," says Noelani Gonzalez, MD

April 30, 2019
Significant Improvement in Generalized Pustular Psoriasis

IL-36 receptor blocker tested in rare type of psoriasis

April 16, 2019
New Mechanisms of Action for Common Derm Conditions

'New approaches haven't come out in decades,' says Joel Gelfand

April 9, 2019
Microneedling and Laser Treatment

Tina Alster, MD, explains how she incorporates the sessions into practice

April 2, 2019
Psoriasis Treatments in Non-White Racial Ethnic Groups

Andrew Alexis, MD, discusses presentations from the Skin of Color Society and AAD

March 26, 2019
Treating Molluscum Contagiosum Infection

Dr. Lawrence Eichenfield, MD, looks forward to an FDA approval

March 19, 2019